Ampio Pharmaceuticals, Inc. (AMPE)
- Previous Close
0.2420 - Open
0.2300 - Bid --
- Ask --
- Day's Range
0.3010 - 0.5100 - 52 Week Range
0.2200 - 8.2000 - Volume
7,868 - Avg. Volume
67,631 - Market Cap (intraday)
563,218 - Beta (5Y Monthly) 1.95
- PE Ratio (TTM)
-- - EPS (TTM)
-10.6600 - Earnings Date May 6, 2024 - May 10, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.
ampiopharma.com6
Full Time Employees
December 31
Fiscal Year Ends
--
Sector
--
Industry
Recent News: AMPE
Performance Overview: AMPE
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AMPE
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AMPE
Valuation Measures
Market Cap
563.22k
Enterprise Value
-3.25M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
0.17
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
0.35
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-61.57%
Return on Equity (ttm)
-113.96%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-8.63M
Diluted EPS (ttm)
-10.6600
Balance Sheet and Cash Flow
Total Cash (mrq)
4.12M
Total Debt/Equity (mrq)
13.42%
Levered Free Cash Flow (ttm)
-5.37M
Research Analysis: AMPE
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell